Related Experiment Video

Updated: Jan 27, 2026

Utilizing High Resolution Ultrasound to Monitor Tumor Onset and Growth in Genetically Engineered Pancreatic Cancer Models
06:57

Utilizing High Resolution Ultrasound to Monitor Tumor Onset and Growth in Genetically Engineered Pancreatic Cancer Models

Published on: April 7, 2018

11.4K

Exploring Signaling Pathways and Pancreatic Cancer Treatment Approaches Using Genetic Models

Shorooq Khader1, Anita Thyagarajan1, Ravi P Sahu1

  • 1Department of Pharmacology and Toxicology, Boonshoft School of Medicine at Wright State University, Dayton, OH 45345, United States.

Mini Reviews in Medicinal Chemistry
|March 30, 2019
PubMed

Insights

Pancreatic cancer survival remains low due to complex pathways. This review explores experimental genetic models to improve therapeutic efficacy against pancreatic cancer.

Area of Science:

  • Oncology
  • Cancer Genetics
  • Drug Discovery

Background:

  • Pancreatic cancer exhibits dismal survival rates despite existing treatments.
  • Counter-regulatory pathways and genetic alterations impede therapeutic efficacy.
  • The role of unknown pathways necessitates novel therapeutic strategies.

Purpose of the Study:

  • To review recent advancements in experimental genetic models for pancreatic cancer.
  • To highlight the significance of these models in evaluating anti-tumor agent efficacy.
  • To explore therapeutic approaches including chemotherapy, natural products, and immunotherapy.

Main Methods:

  • Review of experimental genetic models in pancreatic cancer research.
  • Analysis of signaling cascades' impact on pathophysiology and treatment.
  • Evaluation of therapeutic agents' efficacy in preclinical models.

Main Results:

  • Genetic models are crucial for understanding pancreatic cancer progression.
  • These models aid in assessing the effectiveness of various anti-cancer agents.
  • Combinatorial therapies show promise in preclinical settings.

Conclusions:

  • Experimental genetic models are vital for advancing pancreatic cancer treatment.
  • Understanding pathway interactions is key to overcoming therapeutic resistance.
  • Further research into novel genetic models can improve patient outcomes.
Keywords:
Pancreatic cancercellular signaling pathwaysgenetic modelsimmune-based approachesnatural compoundspancreatic cancer therapies.

More Related Videos

Patient-derived Heterogeneous Xenograft Model of Pancreatic Cancer Using Zebrafish Larvae as Hosts for Comparative Drug Assessment09:56

Patient-derived Heterogeneous Xenograft Model of Pancreatic Cancer Using Zebrafish Larvae as Hosts for Comparative Drug Assessment

Published on: April 30, 2019

9.6K
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

20.1K

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.3K
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.5K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
9.9K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
2.9K
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
14.4K
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
6.2K